### ðŸ«€ Valvular Heart Disease: Endocarditis Prophylaxis for Prosthetic Valves

#### âœ… True Statements
1. **Infective endocarditis prophylaxis** is indicated for patients with a **prosthetic heart valve** who undergo **dental procedures** that involve manipulation of gingival tissue, the periapical region of the teeth, or perforation of the oral mucosa.
2. In patients without a **penicillin allergy**, the preferred regimen for endocarditis prophylaxis is **oral amoxicillin**, administered **30â€¯â€“â€¯60â€¯minutes before** the dental procedure.
3. Acceptable antibiotic alternatives for endocarditis prophylaxis in **penicillinâ€‘allergic** patients include **azithromycin**, **cephalexin**, **doxycycline**, and **clarithromycin**.
4. **Clindamycin** is **no longer recommended** for infective endocarditis prophylaxis in any setting.
5. **Intravenous ceftriaxone, ampicillin, or cefazolin** may be used for endocarditis prophylaxis only when the patient is unable to take oral medications.
6. Endocarditis prophylaxis is **not recommended** for patients undergoing dental procedures **who do not have a highâ€‘risk cardiac condition**, such as a prosthetic valve, prior endocarditis, certain congenital heart diseases, or cardiac transplant with valve regurgitation due to structural abnormality.

#### ðŸ’¬ Extra
1. Prosthetic valves present a nidus for infection by oral flora introduced during invasive dental work, placing affected patients at high risk for **infective endocarditis**.
2. Timing ensures adequate serum antibiotic levels at the moment of bacteremia caused by the procedure.
3. These agents provide gramâ€‘positive coverage of viridans group streptococci when **Î²â€‘lactams** cannot be used.
4. Rising resistance and poor efficacy, along with adverseâ€‘event concerns, led to removal of clindamycin from prophylaxis guidelines.
5. Parenteral therapy is reserved for patients who cannot swallow or absorb oral drugs; dosing mirrors amoxicillin equivalents.
6. Routine prophylaxis for lowâ€‘risk patients does not improve outcomes and exposes them to unnecessary antibiotic side effects.

#### ðŸ”· Tags
#Cardiology #AmbulatoryCare #PatientOver65 #ValvularHeartDisease #EndocarditisProphylaxis #DentalProcedure

#### ðŸ“™ Reference
Otto CM, Nishimura RA, Bonow RO, etâ€¯al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease. *Circulation*. 2021;143:e72â€‘e227. PMID: 33332150. doi:10.1161/CIR.0000000000000923

#### ðŸ†” Question ID
CVMCQ24123

#### ðŸ•’ Last Updated
Februaryâ€¯2025

---

#### ðŸ“– Related Text
MKSAP 19: Cardiovascular Medicine â€” Valvular Heart Disease, Infective Endocarditis

---

### ðŸ“˜ Related Text Derivations

#### âœ… True Statements
1. **Infective endocarditis is a common complication** of **valvular heart disease**.
2. **Antimicrobial prophylaxis** is only indicated for **high-risk patients** undergoing **dental procedures** involving **manipulation of gingival tissue**, **periapical regions of teeth**, or **perforation of the oral mucosa**.
3. The **same high-risk cardiac conditions** listed in the main text apply for determining **prophylaxis eligibility** before dental procedures.
4. **Cardiac implantable electronic deviceâ€“related infections** are discussed separately in dedicated guidance on device infections.
5. The **diagnosis and management** of infective endocarditis are covered in sections beyond prophylaxis guidance.

#### ðŸ’¬ Extra (for Related Text)
1. Endocarditis risk increases in the presence of structural valve disease, especially when turbulence or damage to the endocardium occurs.
2. These procedures create microtrauma or transient bacteremia, which is the rationale for targeting high-risk cardiac conditions.
3. The same list of high-risk indicationsâ€”prosthetic valves, previous endocarditis, certain congenital heart diseasesâ€”is echoed across all guideline-based sources.
4. Device-related infections (e.g., pacemakers, ICDs) are managed under separate protocols because they have distinct microbiologic and procedural risk profiles.
5. Diagnosis and treatment of active infective endocarditis involve blood cultures, imaging (e.g., transesophageal echocardiography), and prolonged intravenous antibiotics or surgery.

#### ðŸ”· Tags
#Cardiology #ValvularHeartDisease #InfectiveEndocarditis #DentalProphylaxis #AmbulatoryCare

#### ðŸ“™ Reference
Wilson WR, Gewitz M, Lockhart PB, et al; American Heart Association Young Hearts Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; and the Council on Quality of Care and Outcomes Research. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. *Circulation*. 2021;e963-e978. PMID: 33853363. doi:10.1161/CIR.0000000000000969

#### ðŸ†” Question ID
CVQQQ24016

#### ðŸ•’ Last Updated
January 2025

<!-- Infective Endocarditis Prophylaxis Table -->
<table>
  <caption><strong>Prophylactic Infective Endocarditis Regimens for Adults at Highest Risk for an Adverse Outcome Before a Dental Procedure</strong></caption>
  <thead>
    <tr>
      <th>Situation</th>
      <th>Agent</th>
      <th>Dosage<sup>a</sup></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Oral</td>
      <td>Amoxicillin</td>
      <td>2 g</td>
    </tr>
    <tr>
      <td rowspan="2">Unable to take oral medication</td>
      <td>Ampicillin</td>
      <td>2 g IM or IV</td>
    </tr>
    <tr>
      <td><em>or</em> Cefazolin or ceftriaxone</td>
      <td>1 g IM or IV</td>
    </tr>
    <tr>
      <td rowspan="4">Allergic to penicillin or ampicillinâ€”oral</td>
      <td>Cephalexin<sup>b,c</sup></td>
      <td>2 g</td>
    </tr>
    <tr>
      <td><em>or</em> Azithromycin or clarithromycin</td>
      <td>500 mg</td>
    </tr>
    <tr>
      <td><em>or</em> Doxycycline</td>
      <td>100 mg</td>
    </tr>
    <tr>
      <td colspan="3"></td>
    </tr>
    <tr>
      <td>Allergic to penicillin or ampicillin and unable to take oral medication</td>
      <td>Cefazolin or ceftriaxone</td>
      <td>1 g IM or IV</td>
    </tr>
  </tbody>
</table>

<p><sup>IM</sup> = intramuscular; <sup>IV</sup> = intravenous.</p>
<p><sup>a</sup>Regimen consists of a single dose 30 to 60 minutes before the dental procedure, or if inadvertently not administered, drug may be given up to 2 hours after the procedure.</p>
<p><sup>b</sup>Or other first- or second-generation oral cephalosporin in equivalent adult dosage.</p>
<p><sup>c</sup>Cephalosporins should not be used in an individual with a history of anaphylaxis, angioedema, or urticaria with penicillins or ampicillin.</p>
<p><strong>Source:</strong> Wilson WR, Gewitz M, Lockhart PB, et al; American Heart Association Young Hearts Rheumatic Fever, Endocarditis and Kawasaki Disease Committee... Circulation. 2021; e963â€“e978. 
<a href="https://doi.org/10.1161/CIR.0000000000000969">PMID: 33853363</a></p>